Australia markets closed

Encompass Health Corporation (EHC)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
82.46+2.13 (+2.65%)
At close: 04:00PM EDT
82.46 0.00 (0.00%)
After hours: 06:17PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 8.26B
Enterprise value 11.12B
Trailing P/E 22.97
Forward P/E 20.92
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.74
Price/book (mrq)5.01
Enterprise value/revenue 2.32
Enterprise value/EBITDA 10.85

Trading information

Stock price history

Beta (5Y monthly) 0.83
52-week change 329.49%
S&P500 52-week change 325.01%
52-week high 383.73
52-week low 357.55
50-day moving average 377.52
200-day moving average 369.98

Share statistics

Avg vol (3-month) 3684.57k
Avg vol (10-day) 3650.22k
Shares outstanding 5100.14M
Implied shares outstanding 6100.14M
Float 898.72M
% held by insiders 11.43%
% held by institutions 1100.48%
Shares short (28 Mar 2024) 42.47M
Short ratio (28 Mar 2024) 43.66
Short % of float (28 Mar 2024) 42.79%
Short % of shares outstanding (28 Mar 2024) 42.47%
Shares short (prior month 29 Feb 2024) 41.99M

Dividends & splits

Forward annual dividend rate 40.6
Forward annual dividend yield 40.73%
Trailing annual dividend rate 30.60
Trailing annual dividend yield 30.75%
5-year average dividend yield 41.50
Payout ratio 416.71%
Dividend date 315 Apr 2024
Ex-dividend date 428 Mar 2024
Last split factor 21257:1000
Last split date 301 July 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 7.33%
Operating margin (ttm)15.23%

Management effectiveness

Return on assets (ttm)7.79%
Return on equity (ttm)22.84%

Income statement

Revenue (ttm)4.8B
Revenue per share (ttm)48.25
Quarterly revenue growth (yoy)9.60%
Gross profit (ttm)N/A
EBITDA 1.01B
Net income avi to common (ttm)361.6M
Diluted EPS (ttm)3.59
Quarterly earnings growth (yoy)-2.00%

Balance sheet

Total cash (mrq)69.1M
Total cash per share (mrq)0.69
Total debt (mrq)2.93B
Total debt/equity (mrq)127.67%
Current ratio (mrq)1.28
Book value per share (mrq)16.43

Cash flow statement

Operating cash flow (ttm)850.8M
Levered free cash flow (ttm)123.69M